RhumbLine Advisers
TSVT

RhumbLine Advisers’s 2seventy bio TSVT Stock Holding History

RhumbLine Advisers’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-84,817
Closed -$419K – 4264
2025
Q1 		$419K Buy
84,817
+147
+0.2% +$467 ﹤0.01% 2682
2024
Q4 		$249K Buy
84,670
+7,379
+10% +$30.3K ﹤0.01% 3090
2024
Q3 		$365K Sell
77,291
-3,927
-5% -$17.7K ﹤0.01% 2915
2024
Q2 		$313K Sell
81,218
-444
-0.5% -$2K ﹤0.01% 2975
2024
Q1 		$437K Buy
81,662
+1,628
+2% +$7.66K ﹤0.01% 2747
2023
Q4 		$342K Sell
80,034
-422
-0.5% -$1.3K ﹤0.01% 2901
2023
Q3 		$315K Buy
80,456
+399
+0.5% +$2.62K ﹤0.01% 2906
2023
Q2 		$810K Buy
80,057
+19,967
+33% +$211K ﹤0.01% 2412
2023
Q1 		$613K Buy
60,090
+1,930
+3% +$22.1K ﹤0.01% 2349
2022
Q4 		$545K Buy
58,160
+612
+1% +$8.63K ﹤0.01% 2425
2022
Q3 		$837K Buy
57,548
+3,246
+6% +$48.2K ﹤0.01% 2238
2022
Q2 		$717K Buy
54,302
+24,197
+80% +$330K ﹤0.01% 2312
2022
Q1 		$514K Sell
30,105
-2,353
-7% -$39.9K ﹤0.01% 2413
2021
Q4 		$832K Buy
+32,458
New +$1.01M ﹤0.01% 2281

Other funds holding TSVT

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

RhumbLine Advisers's TSVT Position: Q2 2025 in Review

RhumbLine Advisers sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 84,817 shares — an estimated $419K sold.

RhumbLine Advisers first reported a position in TSVT in Q4 2021 and held it in 14 quarters. The position peaked at $837K in Q3 2022. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • RhumbLine Advisers reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • RhumbLine Advisers sold 84,817 2seventy bio shares in Q2 2025, an estimated $419K.
  • RhumbLine Advisers first reported a position in 2seventy bio in Q4 2021 and held it in 14 quarters.
  • RhumbLine Advisers's 2seventy bio position peaked at $837K in Q3 2022.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on RhumbLine Advisers's 13F filing for Q2 2025, filed 12 Aug 2025.